article thumbnail

Position Statement on Measurement Based Care

Integrated Care News by CFHA

MBC is presented not simply as data collection, but as a dynamic, evidence-based clinical process that enhances outcomes, promotes equity, and strengthens team-based care. MBC supports optimal clinical practice, demonstrates the value of integrated care teams, and improves outcomes. What is MBC? 3, 4) Why is MBC important? 1, 8, 9) d.

article thumbnail

Comorbidities Influence Optic Outcomes in NMOSD

Physician's Weekly

They evaluated 442 participants from the Collaborative Retrospective Study of Retinal Optical Coherence Tomography in Neuromyelitis optica (CROCTINO) cohort for comorbidities which included 515 individuals—369 with AQP4-NMOSD, 54 with MOGAD, and 58 with DN-NMOSD—meeting the 2006 and 2015 diagnostic criteria for NMOSD.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 176: Antiracism in Medicine Series – Episode 8 – Towards Justice and Race Conscious Medicine

The Clinical Problem Solvers

The answer to this question may not be easily answered and may not always be found in the clinical setting. Rather than searching for obscure explanations for inequalities, we must instead recognize the ways that racism impedes health at both individual and structural levels. For example, GFR- race correction for Black patients.

article thumbnail

Episode 293 – Antiracism in Medicine Series – Episode 22 – Live from SGIM 2023: Best of Antiracism Research at the Society of General Internal Medicine’s 2023 Annual Meeting

The Clinical Problem Solvers

Dr. Beach has won numerous awards for her scholarship and mentorship, including the David Levine Mentoring Award from the Johns Hopkins School of Medicine in 2015. Following residency, she was a Robert Wood Johnson Clinical Scholar and received health services research methodology training. Preserve the dignity of the patient.

article thumbnail

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law Blog

Regulating LDTs: A Long and Winding Road In what might sound to some like protesting too much, the PR invokes FDA’s longstanding assertion that IVDs “manufactured” by laboratories are medical devices and that clinical laboratories that develop tests are acting as manufacturers. FDA’s position is, however, only one side of the story.

article thumbnail

It’s a Cruel Summer – Two New OPDP Untitled Letters

FDA Law Blog

In other words, individuals may not be as vigilant about avoiding allergens if they only hear the benefits of AUVI-Q without understanding there may be safety consequences as well. Honestly, we are pretty shocked that this social media post slipped through the review committee.

Clinic 59
article thumbnail

eMDR System Enhancements

FDA Law Blog

Since the final rule took effect on August 14, 2015, medical device manufacturers and importers have been required to submit MDRs in an electronic format. Those who use eSubmitter will notice changes in the electronic 3500A template in the first week of March.